Second, the microarray-based bioinformatic analysis is powerful in analyzing the molecular mechanisms and in verifying the effects of IL4I1 as a potential biomarker of poor prognosis in thyroid cancer, but experiments may be needed to confirm the relationship and the regulation of IL4I1 on immune cells in the tumor microenvironment. This evidence concerns the gene IL4I1 and thyroid gland carcinoma.